{"id":"https://openalex.org/W60199758","doi":null,"title":"Triamcinolone acetonide and fluticasone propionate nasal sprays provide comparable relief of seasonal allergic rhinitis symptoms regardless of disease severity.","display_name":"Triamcinolone acetonide and fluticasone propionate nasal sprays provide comparable relief of seasonal allergic rhinitis symptoms regardless of disease severity.","publication_year":2004,"publication_date":"2004-11-01","ids":{"openalex":"https://openalex.org/W60199758","mag":"60199758","pmid":"https://pubmed.ncbi.nlm.nih.gov/15709453"},"language":"en","primary_location":{"id":"pmid:15709453","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15709453","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Allergy and asthma proceedings","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110058812","display_name":"Harold B. Kaiser","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Harold B Kaiser","raw_affiliation_strings":["Clinical Research Institute, Minneapolis, Minnesota, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Institute, Minneapolis, Minnesota, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051911660","display_name":"Yuning Liao","orcid":"https://orcid.org/0000-0003-0343-1933","observed_orcids":["https://orcid.org/0000-0003-0343-1933","https://orcid.org/0009-0003-0767-3937"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuning Liao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059189842","display_name":"Phyllis Diener","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Phyllis Diener","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Michael J Leahy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael J Leahy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108554596","display_name":"Jorge Garcia","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jorge Garcia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5025047595","display_name":"George C. Georges","orcid":"https://orcid.org/0000-0002-0303-2273","observed_orcids":["https://orcid.org/0000-0002-0303-2273"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"George Georges","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.5264,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.6338302,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"25","issue":"6","first_page":"423","last_page":"8"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10877","display_name":"Allergic Rhinitis and Sensitization","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10877","display_name":"Allergic Rhinitis and Sensitization","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10984","display_name":"Sinusitis and nasal conditions","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/triamcinolone-acetonide","display_name":"triamcinolone acetonide","score":0.9580000042915344},{"id":"https://openalex.org/keywords/fluticasone-propionate","display_name":"fluticasone propionate","score":1.0},{"id":"https://openalex.org/keywords/intranasal-corticosteroids","display_name":"intranasal corticosteroids","score":0.7870000004768372},{"id":"https://openalex.org/keywords/allergic-rhinitis","display_name":"allergic rhinitis","score":0.9520000219345093},{"id":"https://openalex.org/keywords/symptom-severity","display_name":"symptom severity","score":0.6940000057220459},{"id":"https://openalex.org/keywords/health-related-quality-of-life","display_name":"health-related quality of life","score":0.9049999713897705},{"id":"https://openalex.org/keywords/total-nasal-symptom-score","display_name":"Total Nasal Symptom Score","score":0.9210000038146973},{"id":"https://openalex.org/keywords/nasal-congestion","display_name":"nasal congestion","score":0.6430000066757202},{"id":"https://openalex.org/keywords/rhinorrhea","display_name":"rhinorrhea","score":0.968999981880188},{"id":"https://openalex.org/keywords/sneezing","display_name":"sneezing","score":0.9670000076293945},{"id":"https://openalex.org/keywords/nasal-itching","display_name":"nasal itching","score":0.9909999966621399},{"id":"https://openalex.org/keywords/once-daily-dosing","display_name":"once-daily dosing","score":0.7149999737739563},{"id":"https://openalex.org/keywords/drug-comparison","display_name":"drug comparison","score":0.5830000042915344},{"id":"https://openalex.org/keywords/corticosteroid-potency","display_name":"corticosteroid potency","score":0.4059999883174896},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.3630000054836273},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.32600000500679016}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9064412117004395},{"id":"https://openalex.org/C2779028295","wikidata":"https://www.wikidata.org/wiki/Q8564098","display_name":"Fluticasone propionate","level":3,"score":0.8266274929046631},{"id":"https://openalex.org/C2779699568","wikidata":"https://www.wikidata.org/wiki/Q1115038","display_name":"rhinorrhea","level":2,"score":0.6595794558525085},{"id":"https://openalex.org/C2778903070","wikidata":"https://www.wikidata.org/wiki/Q2211240","display_name":"Triamcinolone acetonide","level":2,"score":0.6469914317131042},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5698369741439819},{"id":"https://openalex.org/C2780973058","wikidata":"https://www.wikidata.org/wiki/Q1755275","display_name":"Nasal spray","level":3,"score":0.5570547580718994},{"id":"https://openalex.org/C2779923671","wikidata":"https://www.wikidata.org/wiki/Q199602","display_name":"Itching","level":2,"score":0.491792231798172},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.47023624181747437},{"id":"https://openalex.org/C2777844070","wikidata":"https://www.wikidata.org/wiki/Q3245488","display_name":"Nasal congestion","level":3,"score":0.4550098776817322},{"id":"https://openalex.org/C2776804153","wikidata":"https://www.wikidata.org/wiki/Q210420","display_name":"Corticosteroid","level":2,"score":0.42566001415252686},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.4255257248878479},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3990011215209961},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.36543017625808716},{"id":"https://openalex.org/C2778311950","wikidata":"https://www.wikidata.org/wiki/Q7363","display_name":"Nose","level":2,"score":0.27242493629455566},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.25988689064979553},{"id":"https://openalex.org/C85663871","wikidata":"https://www.wikidata.org/wiki/Q6966562","display_name":"Nasal administration","level":2,"score":0.14214441180229187},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.09201768040657043}],"mesh":[{"descriptor_ui":"D000281","descriptor_name":"Administration, Intranasal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003430","descriptor_name":"Cross-Sectional Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011336","descriptor_name":"Probability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012016","descriptor_name":"Reference Values","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012221","descriptor_name":"Rhinitis, Allergic, Perennial","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D012221","descriptor_name":"Rhinitis, Allergic, Perennial","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014222","descriptor_name":"Triamcinolone Acetonide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D016001","descriptor_name":"Confidence Intervals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016037","descriptor_name":"Single-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:15709453","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15709453","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Allergy and asthma proceedings","raw_type":"Clinical Trial"},{"id":"mag:60199758","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15709453","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2017285193","https://openalex.org/W2029154585","https://openalex.org/W2051734838","https://openalex.org/W2034047339","https://openalex.org/W1593743641","https://openalex.org/W2035127448","https://openalex.org/W1970888626","https://openalex.org/W2154797656","https://openalex.org/W3087812774","https://openalex.org/W2077289226"],"abstract_inverted_index":{"The":[0],"aim":[1],"of":[2,10,31,57,80],"this":[3],"study":[4,166],"was":[5,92],"to":[6],"examine":[7],"the":[8,133,155,165,183,205],"effects":[9],"aqueous":[11],"triamcinolone":[12],"acetonide":[13],"(TAA":[14,146,185,207],"AQ)":[15,147],"and":[16,28,85,119,126,141,144,148,161,176,204,227,230,242,255,259],"fluticasone":[17],"propionate":[18],"(FP)":[19,150],"nasal":[20,75,81,86,244],"sprays":[21,245],"on":[22,40],"seasonal":[23],"allergic":[24],"rhinitis":[25],"(SAR)":[26],"symptoms":[27],"health-related":[29],"quality":[30],"life":[32],"(HRQL)":[33],"in":[34,132,154,179,181,234,246,261],"patients":[35,50,91,129,151,168,247],"stratified":[36,98],"into":[37,102],"cohorts":[38],"based":[39],"symptom":[41,76,117,257],"severity.":[42],"In":[43],"a":[44,52,103],"multicenter,":[45],"investigator-blinded,":[46],"parallel-group":[47],"study,":[48],"295":[49],"with":[51,248],">":[53],"or":[54,65,106,109,250],"=2-year":[55],"history":[56],"SAR":[58,252],"received":[59],"once-daily":[60],"TAA":[61,124,225,240],"AQ,":[62,186,208],"220":[63],"microg,":[64,68],"FP,":[66,196,216],"200":[67],"for":[69,89],"3":[70],"weeks.":[71],"Median":[72],"baseline":[73,100,114],"total":[74],"score":[77],"(TNSS;":[78],"sum":[79],"congestion,":[82],"rhinorrhea,":[83],"sneezing,":[84],"itching":[87],"scores)":[88],"all":[90,174],"8.14":[93],"(range,":[94],"0-12).":[95],"Patients":[96],"were":[97,121,130,152],"by":[99],"TNSS":[101,138,180],"moderate":[104,134,184,249],"(<814)":[105],"severe":[107,156,206,251],"(>":[108],"=8.14)":[110],"cohort.":[111],"Changes":[112],"from":[113],"TNSS,":[115],"individual":[116],"scores,":[118],"HRQL":[120,233],"assessed.":[122],"Sixty-nine":[123],"AQ":[125,226,241],"76":[127],"FP":[128,228,243],"included":[131,153],"stratum":[135,157],"(baseline":[136],"mean":[137],"=":[139,159],"6.14":[140],"6.22,":[142],"respectively),":[143],"79":[145],"71":[149],"(TNSS":[158],"10.03":[160],"9.47,":[162],"respectively).":[163],"At":[164],"end,":[167],"showed":[169],"significant":[170,254],"(p":[171],"<":[172],"0.0001":[173],"comparisons)":[175],"comparable":[177,256],"improvements":[178,260],"both":[182,235],"-2.40":[187],"[95%":[188,198,210,218],"confidence":[189],"interval":[190],"[CI,":[191],"-2.92,":[192],"-1.87],":[193],"39%":[194],"improvement;":[195,215],"-2.22":[197],"CI,":[199,211,219],"-2.72,":[200],"-1.73],":[201],"36%":[202],"improvement)":[203,223],"-3.85":[209],"-4.36,":[212],"-3.33],":[213],"38%":[214],"-3.84":[217],"-4.43,":[220],"-3.24],":[221],"41%":[222],"strata.":[224],"significantly":[229],"comparably":[231],"improved":[232],"strata":[236],"versus":[237],"baseline.":[238],"Once-daily":[239],"provided":[253],"relief":[258],"HRQL.":[262]},"counts_by_year":[{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}